Virology & Mycology Infectious Diseases
 
   Publications A-Z
A
»Accounting & Marketing
» Addiction Research & Therapy
»Advances in Automobile Engineering
»Advances in Pharmacoepidemiology & Drug Safety
»Advances in Robotics & Automation
»Aeronautics & Aerospace Engineering
»Agrotechnology
»AIDS & Clinical Research
»Allergy & Therapy
»Air & Water borne Diseases
»Alzheimers Disease & Parkinsonism
»Analytical & Bioanalytical Techniques
»Anaplastology
»Anatomy & Physiology
»Andrology-Open Access
»Anesthesia & Clinical Research
»Antivirals & Antiretrovirals
»Applied & Computational Mathematics
»Applied Mechanical Engineering
»Aquaculture Research & Development
»Architectural Engineering Technology
»Arthritis
»Astrophysics & Aerospace technology
»Autacoids
»Autism-Open Access
  
B
»Bacteriology & Parasitology
»Bioanalysis & Biomedicine
»Biochemistry and Analytical Biochemistry
»Biochemistry & Pharmacology: Open Access
»Biochips & Tissue Chips
»Bioenergetics: Open Access
»Bioengineering & Biomedical Science
»Bioequivalence & Bioavailability
»Biofertilizers & Biopesticides
»Biometrics & Biostatistics
»Biomolecular Research & Therapeutics
»Biochemistry & Physiology: Open Access
»Bioprocessing & Biotechniques
»Bioremediation & Biodegradation
»Biosafety
»Biosensors & Bioelectronics
»Biotechnology & Biomaterials
»Bioterrorism & Biodefense
»Blood Disorders & Transfusion
»Blood & Lymph
»Brain Disorders & Therapy
»Briefing in Intellectual Property Rights
»Business and Financial Affairs
  
C
»Cancer Science & Therapy
»Carcinogenesis & Mutagenesis
»Cell & Developmental Biology
»Cell Science & Therapy
»Chemical Engineering & Process Technology
»Chemotherapy: Open Access
»Chromatography & Separation Techniques
»Civil & Environmental Engineering
»Civil & Legal Sciences
»Clinical & Cellular Immunology
»Clinical Case Reports
»Clinical & Experimental Cardiology
»Clinical & Experimental Dermatology Research
»Clinical & Experimental Ophthalmology
»Clinical & Experimental Pathology
»Clinical & Experimental Pharmacology
»Clinical Pharmacology & Biopharmaceutics
»Clinical Research & Bioethics
»Clinical Toxicology
»Clinical Trials
»Cloning & Transgenesis
»Communicable & Noncommunicable Diseases
»Community Medicine & Health Education
»Computer Science & Systems Biology
»Cytology & Histology
D
»Data Mining in Genomics & Proteomics
»Defense Management
»Dentistry
»Depression and Anxiety
»Diabetes & Metabolism
»Drug Designing
»Drug Metabolism & Toxicology
  
E
»Earth Science & Climatic Change
»Ecosystem & Ecography
»Endocrinology & Metabolic Syndrome
»Entomology, Ornithology & Herpetology
»Environmental & Analytical Toxicology
»Epidemiology: Open Access
»Emergency Medicine
»Ergonomics
»Electrical & Electronics
»Enzyme Engineering
»Entrepreneurship & Organization Management
  
F
»Family Medicine & Medical Science Reserch
»Fermentation Technology
»Fertilization : In Vitro
»Food Processing & Technology
»Forensic Research
»Forest Research: Open Access
»Fungal Genomics & Biology
  
G
»Gastrointestinal & Digestive System
»Genetic Syndromes & Gene Therapy
»Glycobiology
»Glycomics & Lipidomics
»Gynecology& Obstetrics
»Geography & Natural Disasters
»Geology & Geosciences
»Geophysics & Remote Sensing
»Gerontology & Geriatric Research
  
H
»Hair : Therapy & Transplantation
»Health & Medical Informatics
»Hereditary Genetics
»Homeopathy & Ayurvedic Medicine
»Hotel & Business Management
»Human Genetics & Embryology: Current Research
»Hydrology: Current Research
»Hypertension- Open Access
  
I
»Industrial Engineering & Management
»Irrigation and Drainage Systems Engineering
»Information Technology & Software Engineering
»Internal Medicine
»Integrative Oncology
  
L
»Liver
  
M
»Marine Science: Research & Development
»Mass Communication & Journalism
»Material Science & Engineering
»Medicinal Chemistry
»Medical Advancements in Genetic Engineering
»Medicinal & Aromatic Plants
»Medical Diagnostic Methods
»Medical Microbiology & Diagnosis
»Medical & Surgical Urology
»Membrane Science & Technology
»Metabolic Syndrome
»Metabolomics:Open Access
»Microbial & Biochemical Technology
»Molecular Biology
»Molecular Biomarkers & Diagnosis
»Molecular Imaging & Dynamics
»Mycobacterial Diseases
N
»Nanomedicine & Biotherapeutic Discovery
»Nanomedicine & Nanotechnology
»Neonatal Biology
»Nephrology & Therapeutics
»Neurology & Neurophysiology
»Novel Physiotherapies
»Nuclear Energy & Power Generation Technologies
»Nuclear Medicine & Radiation Therapy
»Nutrition & Food Sciences
»Nutritional Disorders & Therapy
»Nursing & Care
  
O
»Obesity & Weight Loss Therapy
»OMICS Journal of Radiology
»Outlook on Developing Drugs: Open Access
»Organ Biology
»Organic Chemistry: Current Research
»Orthopedic & Muscular System: Current Research
»Otolaryngology
  
P
»Pain & Relief
»Palliative Care & Medicine
»Pancreatic Disorders & Therapy
»Pediatrics & Therapeutics
»Petroleum & Environmental Biotechnology
»Pharmaceutica Analytica Acta
»Pharmaceutical Regulatory Affairs: Open Access
»Pharmacogenomics & Pharmacoproteomics
»Physical Chemistry & Biophysics
»Plant Pathology & Microbiology
»Powder Metallurgy & Mining
»Primatology
»Primary Health Care: Open Access
»Proteomics & Bioinformatics
»Psychology & Psychotherapy
»Pulmonary & Respiratory Medicine
  
R
»rDNA Technology
»Reproductive System & Sexual Disorders
»Rheumatology: Current Research
  
S
» Single Cell Genomics & Proteomics
»Sleep Disorders & Therapy
»Social & Economical Issues of Biotechnology
»Socialomics
»Sports Medicine & Doping Studies
»Spine
»Stem Cell Research & Therapy
»Steroids & Hormonal Science
»Stock & Forex Trading
»Surgery: Current Research
  
T
»Telecommunications System & Management
»Textile Science & Engineering
»Thermodynamics & Catalysis
»Thyroid Disorders & Therapy
»Tissue Science & Engineering
»Translational Medicine
»Transplantation Technologies & Research
»Trauma & Treatment
»Tourism & Hospitality
  
V
»Vaccines & Vaccination
»Veterinary Science & Technology
»Virology & Mycology
»Vitamins & Trace Elements
  
W
»Women's Health Care
  
Y
»Yoga & Physical Therapy
 
   Browse by Subjects
Clinical
» AIDS & Clinical Research
» Anesthesia & Clinical Research
» Cancer Science & Therapy
» Carcinogenesis & Mutagenesis
» Cell Science & Therapy
» Clinical & Cellular Immunology
» Clinical & Experimental Cardiology
» Clinical & Experimental Dermatology Research
» Clinical & Experimental Ophthalmology
» Clinical & Experimental Pathology
» Clinical & Experimental Pharmacology
» Clinical Research & Bioethics
» Clinical Toxicology
» Cytology & Histology
» Forensic Research
» Integrative Oncology
» Neurology & Neurophysiology
» Pulmonary & Respiratory Medicine
» Stem Cell Research & Therapy
» Transplantation Technologies & Research
   
Pharmaceutical Sciences
» Advances in Pharmacoepidemiology & Drug Safety
» Antivirals & Antiretrovirals
» Bioanalysis & Biomedicine
» Bioequivalence & Bioavailability
» Clinical Pharmacology & Biopharmaceutics
» Drug Metabolism & Toxicology
» Outlook on Developing Drugs: Open Access
» Pharmaceutica Analytica Acta
» Pharmaceutical Regulatory Affairs: Open Access
» Vaccines & Vaccination
   
Chemistry
» Analytical & Bioanalytical Techniques
» Chromatography & Separation Techniques
» Medicinal Chemistry
» Organic Chemistry
» Physical Chemistry & Biophysics
» Thermodynamics & Catalysis
   
Environmental
» Aquaculture Research & Development
» Earth Science & Climatic Change
» Ecosystem & Ecography
» Environmental & Analytical Toxicology
» Geography & Natural Disasters
» Hydrology: Current Research
» Petroleum & Environmental Biotechnology
   
Omics
» Computer Science & Systems Biology
» Data Mining in Genomics & Proteomics
» Glycomics & Lipidomics
» Health & Medical Informatics
» Metabolomics:Open Access
» Pharmacogenomics & Pharmacoproteomics
» Proteomics & Bioinformatics
   
Life Sciences
» Agrotechnology
» Autism-Open Access
» Bacteriology & Parasitology
» Biochemical Pharmacology
» Biochemistry & Physiology
» Biochemistry & Physiology: Open Access
» Biochemistry and Analytical Biochemistry
» Biochips & Tissue Chips
» Bioenergetics
» Bioengineering & Biomedical Science
» Biofertilizers & Biopesticides
» Biometrics & Biostatistics
» Biomolecular Research & Therapeutics
» Bioremediation & Biodegradation
» Biosafety
» Biosensors & Bioelectronics
» Biotechnology & Biomaterials
» Bioterrorism & Biodefense
» Cell & Developmental Biology
» Chemotherapy
» Enzyme Engineering
» Fermentation Technology
» Forest Research
» Fungal Genomics & Biology
» Marine Science: Research & Development
» Medical Advancements in Genetic Engineering
» Medicinal & Aromatic Plants
» Membrane Science & Technology
» Microbial & Biochemical Technology
» Molecular Imaging & Dynamics
» Nanomedicine & Biotherapeutic Discovery
» Nanomedicine & Nanotechnology
» Nutrition & Food Sciences
» Plant Pathology & Microbiology
» Primatology
» rDNA Technology
» Single Cell Genomics & Proteomics
» Social & Economical Issues of Biotechnology
» Tissue Science & Engineering
» Veterinary Science & Technology
» Virology & Mycology
» Vitamins & Trace Elements
» Women's Health Care
» Yoga & Physical Therapy
   
Engineering
» Advances in Automobile Engineering
» Advances in Robotics & Automation
» Aeronautics & Aerospace Engineering
» Applied & Computational Mathematics
» Applied Mechanical Engineering
» Architectural Engineering Technology
» Astrophysics & Aerospace technology
» Bioprocessing & Biotechniques
» Chemical Engineering & Process Technology
» Civil & Environmental Engineering
» Electrical & Electronics
» Food Processing & Technology
» Geology and Geosciences
» Geophysics & Remote sensing
» Industrial Engineering & Management
» Information Technology & Software Engineering
» Irrigation and Drainage Systems Engineering
» Material Science & Engineering
» Powder Metallurgy & Mining
» Telecommunications System & Management
» Textile Science & Engineering
   
Medical Sciences
» Addiction Research & Therapy
» Air & Water borne Diseases
» Allergy & Therapy
» Alzheimers Disease & Parkinsonism
» Anaplastology
» Anatomy & Physiology
» Andrology
» Arthritis
» Autacoids
» Blood & Lymph
» Blood Disorders & Transfusion
» Brain Disorders & Therapy
» Clinical Case Reports
» Clinical Trials
» Cloning & Transgenesis
» Communicable & Noncommunicable Diseases
» Community Medicine & Health Education
» Dentistry
» Depression and Anxiety
» Diabetes & Metabolism
» Drug Designing
» Emergency Medicine
» Endocrinology & Metabolic Syndrome
» Entomology, Ornithology & Herpetology
» Epidemiology: Open Access
» Ergonomics
» Family Medicine & Medical Science Reserch
» Fertilization : In Vitro
» Gastrointestinal & Digestive System
» Genetic Syndromes & Gene Therapy
» gerontology & Geriatrics Research
» Glycobiology
» Gynecology& Obstetrics
» Hair: Therapy & Transplantation
» Hereditary Genetics
» Homeopathy & Ayurvedic Medicine
» Human Genetics & Embryology
» Hypertension-Open Access
» Internal Medicine
» Liver
» Medical Diagnostic Methods
» Medical Microbiology & Diagnosis
» Metabolic Syndrome
» Molecular Biology
» Molecular Biomarkers & Diagnosis
» Mycobacterial Diseases
» Neonatal Biology
» Nephrology & Therapeutics
» Novel Physiotherapies
» Nuclear Medicine & Radiation Therapy
» Nursing & Care
» Nutritional Disorders & Therapy
» Obesity & Weight Loss Therapy
» OMICS Journal of Radiology
» Organ Biology
» Orthopedic & Muscular System
» Otolaryngology
» Pain & Relief
» Palliative Care & Medicine
» Pancreatic Disorders & Therapy
» Pediatrics & Therapeutics
» Primary Health Care: Open Access
» Psychology & Psychotherapy
» Reproductive System & Sexual Disorders
» Rheumatology: Current Research
» Sleep Disorders & Therapy
» Spine
» Sports Medicine & Doping Studies
» Steroids & Hormonal Science
» Surgery: Current Research
» Thyroid Disorders & Therapy
» Translational Medicine
» Trauma & Treatment
 
Management
» Accounting & Marketing
» Business and Financial Affairs
» Civil & Legal Sciences
» Defense Management
» Entrepreneurship& Organization Management
» Hotel & Business Management
» Industrial Engineering & Management
» Mass Communication & Journalism
» Stock & Forex Trading
» Socialomics
» Tourism & Hospitality
 
   Conferences
Upcoming Conferences
»3rd International Conference on Biomarkers & Clinical Research July 2-4, 2012 Las Vegas, USA.
»2nd International Conference on Proteomics & Bioinformatics July 2-4, 2012 Las Vegas, USA.
»International Conference and Exhibition on Orthopedics August 13-15, 2012 Chicago, USA.
»International Conference and Exhibition on Rheumatology and Therapeutics August 14-15, 2012 Chicago, USA.
»International Conference and Exhibition on Addiction Research & Therapy August 20-22, 2012 Las Vegas, USA.
»2nd World Congress on Virology August 20-22, 2012 Las Vegas, USA.
»International Conference and Exhibition on Nephrology and Therapeutics August 20-22, 2012 Hilton Chicago/Northbrook Chicago, USA.
»2nd International Conference on Vaccines & Vaccination August 20-22, 2012 at Chicago, USA.
»World Congress on Earth Science & Climate Change August 21-22, 2012 Chicago, USA.
»International Conference and Exhibition on pathology August 27-29, 2012 Philadelphia, USA.
»International Conference on Pulmonary & Respiratory Medicine August 27-29, 2012 Philadelphia, USA.
»International Conference and Exhibition on Nutritional Science & Therapy-2012 August 27-29, 2012 Philadelphia, USA.
»International Conference on Central Nervous System September 5-7, 2012 Double by Hilton Philadephia, USA.
»International Conference on Occupational Health and Safety Summit September 5-7, 2012 Philadelphia, USA.
»International Conference on Hydrology and Groundwater Expo September 10-12, 2012 Hilton San Antonio Airport, USA.
»2nd World Congress on Cancer Science & Therapy September 10-12, 2012 San Antonio, USA.
»International Conference and Exhibition on Biowaivers and Biosimilars September 10-12, 2012 San Antonio, TX, USA.
»3rd World Congress on Biotechnology September 13-15, 2012 HICC, Hyderabad, India
»International Conference on Biodiversity & Sustainable Energy Development September 14-15, 2012 Hyderabad, India.
»International Conference and Exhibition on Solar Systems and Power Generation Technologies September 14-15, 2012 Hyderabad International Convention Center, India.
» International Conference on Hotel and Business Management September 14-15, 2012 Hyderabad International Convention Center, India
»International Conference on Toxicology Summit & Expo September 17-19, 2012 San Antonio Texas, USA.
»International Conference on Translational medicine-2012, September 17-19, 2012 Holiday Inn San Antonio, Texas, USA.
»2nd International Conference on Pediatrics & Gynecology September 24-26, 2012, Hyderabad Marriott Hotel & Convention Centre , Hyderabad, India.
»3rd World Congress on Diabetes & Metabolism which is to be held on September 24-26, 2012 Marriott Convention Center, Hyderabad, India.
»International Conference on Tissue Science and Engineering October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA.
»International conference and Exhibition on Pharmacovigilance and Clinical Trials October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA.
»Omics International Integrative Biology Summit 2012 October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference on Emerging Cell Therapies October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference on Forensic Research & Technology October 15-17, 2012 at DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference and Exhibition on Otolaryngology October 15-17, 2012 Chicago, USA.
»International conference on Biothreats and Biodefense October 15-17, 2012 at DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference on Genetic Syndromes & GeneTherapy November 19-21, 2012 at Hilton San Antonio Airport, USA.
»International Conference on Clinical and Cellular Immunology October 22-24, 2012 Las Vegas, USA.
»International Conference and Expo on Material science and Engineering October 22-24, 2012 DoubleTree by Hilton Chicago-North Shore, USA.
» International Expo and Conference on Analytrix & HPLC October 22-24, 2012 Hilton Northbrook, Chicago, USA.
»International Conference and Exhibition on Computer Aided Drug Design & QSAR October 29-31, 2012, Chicago, USA.
»International Conference and Exhibition on Personalized Medicine & Molecular Diagnostics during October 29-31, 2012 DoubleTree by Hilton Chicago-North Shore, USA.
»2nd World Congress on Cell Science and Stem Cell Research November 12-14, 2012 Hilton San Antonio Airport, USA.
»International Conference on Clinical Microbiology & Microbial Genomics November 12-14, 2012 San Antonio, USA.
»International Conference on Regenerative and Functional Medicine November 12-14, 2012 at San Antonio, Texas, USA.
»Global Biofuels and Bioproducts Summit November 19-21, 2012 San Antonio, USA.
»International Conference on Genetic Syndromes & GeneTherapy November 19 - 21, 2012 Hilton San Antonio Airport, USA
»International Conference and Exhibition on Probiotics-2012, November 19–21, 2012, Hilton San Antonio Airport, USA.
»International Conference and Exhibition on Food Processing and Technology November 22-24, 2012 Hyderabad, India.
»3rd International Conference and Exhibition on Analytical & Bioanalytical Techniques November 22-24, 2012 Hyderabad International Convention Center, India
»2ndInternational Conference and Exhibition on Pharmaceutical Regulatory Affairs November 23-24, 2012 HICC Hyderabad, India
»International Conference and Exhibition on Cosmetology & Cosmetics November 23-24, 2012 HICC Hyderabad, India.
»International Conference and Exhibition on Surgery & Transplantation November 26-28, 2012 Hilton San Antonio Airport, USA.
»International conference on Hair Transplantation and Trichology November 26-28, 2012 San Antonio, USA.
»International Conference on Anesthesia & Perioperative Care during November 26-28, 2012 San Antonio, USA.
»International Conference and Exhibition on Obesity and Weight Management, December 3-5, 2012 at DoubleTree by Hilton Philadelphia, USA.
»International Summit on GMP & GCP: USA, Europe, Japan, Asia Pacific December 3-5, 2012 DoubleTree by Hilton Philadelphia Center City, USA
»International Conference on QA, QC and Validation, December 3-5, 2012 DoubleTree by Hilton Philadelphia Center City, USA
»2nd International Conference on Nanotek and Expo, December 3-5, 2012 DoubleTree by Hilton Philadelphia Center City, USA
Previous Conferences Organized/Co-organized
» International Conference and Exhibition on Neurology &Therapeutics May 14-16, 2012 Embassy Suites Las Vegas, USA.
»International Conference and Exhibition on Biosensors & Bioelectronics May 14-16, 2012 Embassy Suites Las Vegas, USA.
»3rd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit March 26-28, 2012 Marriott Hotel, Hyderabad, India.
»International Conference & Exhibition on Nanotechnology and Nanomedicine March 12-14, 2012 Omaha, USA.
»World Congress on Gastroenterology and Urology March 12-14, 2012 Omaha, USA
»International Conference and Exhibition on Biometrics & Biostatistics March 5-7, 2012 Omaha, USA.
»2nd World Congress on Clinical & Experimental Dermatology March 5-7, 2012 Omaha, USA
»2nd World Congress on Clinical & Experimental Cardiology March 5-7, 2012 Omaha, USA.
» 2nd World Congress on Clinical & Experimental Ophthalmology March 5-7, 2012 Omaha, USA.
»International Conference and Exhibition on Metabolomics & Systems Biology February 20-22, 2012 San Francisco, USA.
»2nd World Congress on Pharmaceutics & Novel Drug Delivery Systems February 20-22, 2012 San Francisco, USA.
»2nd world Congress on Analytical and Bioanalytical Techniques 16-17 December 2011San franscico, USA.
»2nd World Congress on Diabetes & Metabolism 6-8 December 2011 Philadelphia, USA.
»World Congress on Pediatrics & Gynecology 6-8 December 2011 Philadelphia, USA.
»International Conference and Exhibition on Cell Science & Stem Cell Research 29 Nov-1 Dec 2011 Philadelphia, USA.
»2nd World Congress on Biotechnology 29 Nov -1 Dec 2011 Philadelphia, USA.
»International Conference and Exhibition on Vaccines & Vaccination 22-24 November 2011 Philadelphia, USA.
»2nd World Congress on Biomarkers & Clinical Research 12-14 September 2011 Baltimore, USA.
»International Conference and Exhibition on Virology 5-7 September 2011 Baltimore, USA.
»International Conference and Exhibition on Pharmaceutical Regulatory Affairs 6-7 September 2011 Baltimore, USA.
»International Conference and Exhibition on Cancer Science & Therapy 15-17 August 2011 Las Vegas, USA.
»International Conference on Clinical Research: Dermatology, Ophthalmology and Cardiology 5-6 July 2011 San Francisco, USA.
»International Conference & Exhibition on Proteomics & Bioinformatics 6-8 June 2011 HICC, Hyderabad, India.
»International Conference & Exhibition on Pharmaceutical Biotechnology 6-8 June 2011 HICC, Hyderabad, India.
»2nd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit 6-8 June 2011 Las Vegas, USA.
»International Conference on Pharmaceutics & Novel Drug Delivery Systems 7-8 June Las Vegas, USA.
»World Congress on Biotechnology 21-23 March 2011 Hyderabad, India.
»International Conference on Diabetes and Metabolism 13-14 December 2010 Santa Clara, USA.
»International Conference on Biomarkers & Clinical Research 22-23 November 2010 Santa Clara, USA
»International Conference and Exhibition on Analytical and Bioanalytical Techniques: Pharmaceutical R & D Summit 01 - 03 November 2010 Hyderabad, India
»International Conference & Exhibition on Bioequivalence & Bioavailability 2010, Pharmaceutical R & D Summit March 01-03, 2010.
»Integrating Glycomics with other Omics in Cancer Detection and Diagnosis, January 19-20, 2010, Stanford University School of Medicine.
»3rd World Congress of Gene-2009, December 1-7, 2009.
»7th Annual World Congress of International Drug Discovery Science & Technology, October 22-25.
»2nd WSA-2009, July 18-20, 2009
»1st CCSB-2009, February 16-17, 2009
»2nd PRICPS-4th AOHUPO, June 22-26, 2008
»95th ISCA, January 5-8, 2008

Search :     Advanced Search 

Home   |   Join   |   Contact     

    
Journal Details
 
 
Research Article Open Access
Preparation, Characterization and Pharmacokinetics in Vivo of Oxymatrine–Phospholipid Complex
Peng-Fei YUE1,2, Hai-Long YUAN3,*, Ming Yang1, Wei-Feng ZHU1
1Jiangxi University of Traditional Chinese Medicine,Nanchang 330004
2Key Lab of Modern Preparation of TCM, Ministry of Education, Nanchang 330004
3302 Hospital of PLA&PLA Institute of Chinese Materia Medica, Beijing 100039
*Corresponding author: Dr. Hai-Long Yuan,
302 Hospital of PLA&PLA Institute of Chinese Materia Medica,
Beijing, China,
Phone : 86-10-66933324,
Fax      : 86-10-63879915,
E-mail : ypfpharm@126.com
 
Received August 19, 2009; Accepted October 23, 2009; Published October 23, 2009
 
Citation: Yue PF, Yuan HL, Yang M, Zhu WF (2009) Preparation, Characterization and Pharmacokinetics in Vivo of Oxymatrine–Phospholipid Complex. J Bioequiv Availab 1: 099-102. doi:10.4172/jbb.1000015
 
Copyright: © 2009 Yue PF, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 
Abstract
 
The aim of the present study was to prepare oxymatrine– phospholipid complex to enhance oral bioavailability of oxymatrine and to study its physicochemical properties and to compare the pharmacokinetic characteristics and bioavailability after oral administration of oxymatrine– phospholipid complex in rats. Using tetrahydrofuran as a reaction medium, oxymatrine and phospholipids were resolved into the medium, after the organic solvent was removed under vacuum condition, oxymatrine–phospholipid complex was formed. The new complex’s physicochemical properties including differential scanning calorimetry (DSC), X-ray diffraction (XRD), N-octanol/water Partition Coefficient were tested. The concentrations of oxymatrine after oral administration of oxymatrine–phospholipids complex and oxymatrine at different time in rats were determined by HPCE. The pharmacokinetic parameters were computed by software program 3p87. The data showed that oxymatrine and phospholipids in the oxymatrine–phospholipid complex were combined by noncovalent bond, not forming a new compound and the solubility of oxymatrine –phospholipid complex in n-octanol was effectively enhanced. The better hepatocytes permeability was obtained by the phospholipid complex. We found that mean plasma concentration–time curve of oxymatrine after oral administration of oxymatrine–phospholipid complex and oxymatrine in rats was both in accordance with open two-compartment model with firstorder absorption. Pharmacokinetic parameters of oxymatrine ,physical mixture and the complex in rats were Tmax 1.71, 1.91and 2.17 h, Cmax 0.164,0.247 and 0.437μg·ml-1, AUC0–∞ 2.87, 3.23 and 9.43μg·h·ml-1, respectively. The bioavailability of oxymatrine in rats was increased remarkably after oral administration of oxymatrine–phospholipid complex comparing to oxymatrine and the physical mixture. This was mainly due to an impressive improvement of the lipophilic property of oxymatrine–phospholipid complex.
 
Keywords
 
Oxymatrine; Phospholipid complex; Physicochemical properties; Pharmacokinetics
 
Introduction
 
Oxymatrine(OMT) is a kind of alkaloid extracted from a Chinese herb (Sophora alopecuraides L.) (Lai et al., 2003). Basic and clinical researches suggested that oxymatrine had the following pharmacological effects such as anti-virus, protecting hepatocytes, anti-hepatic fibrosis, immune regulation, etc (Liu et al., 2003; Dong et al., 2003; Xiang et al., 2002; Yang et al., 2002; Chen et al., 2001; Li et al., 1998). In particular, wide attention was paid to its inhibitory effect on hepatitis B virus (HBV) in recent years. Oxymatrine has been proved to have distinct anti-virus effect in the treatment of chronic hepatitis B (CHB). The slight liposolubility of oxymatrine result in the poor permeation across the intestinal epithelial cells and minor the gastrointestinal (GI) tract absorption in rats (Chen et al., 2002; Yu et al., 2002; Chen et al., 2001; Wang et al., 2000). So the wide clinical application of oxymatrine remains a question because of the poor clinical therapeutic effect after oral administration. There are usually several factors responsible for this, but a particularly widespread problem is poor absorption due to slow in the lumen of the gastro-intestinal tract. There are numerous advantages of phospholipids in addition to solubilizing property while considering them for a carrier system. Phospholipids are an important component of cell membrane, having the actions of keeping cell membrane fluidity and treating hepatic disorder. In this paper, OMT–phospholipid complex (OMT-PLC) was studied in order to improve oral bioavailability of OMT.
 
The object ive of this study is: (1) to improve oral bioavailability of OMT, OMT-phospholipid complex was prepared. It is expected that OMT combined with phospholipids might increase the oral bioavailability; (2) the physicochemical characters of OMT-PLC were evaluated, such as DSC, XRD. The n-octanol/water partition coefficient (P) study of OMT-PLC was performed in order to evaluate the improved solubility properties of OMT-PLC in comparison with OMT material and the physical mixture; (3) After oral administration of three formulations: OMT, the physical mixture and OMT-PLC, the pharmacokinetics and bioavailability of OMT in rats were studied. The formulation OMT-PLC, which exhibits comparable to the commercial products or even higher bioavailability, may be clinical candidate for future clinical study.
 
Materials and Methods
 
Materials
 
Oxymatrine was purchased from Ningxia-bo-er-tai-li Ltd, purity 99.13%, and phospholipid was purchased from Hua-qingmei- hen Ltd., and the phosphatidyl content was approximately 82% (w/w). The other chemical reagents were of analytical grade or better.
 
Preparation of Oxymatrine –phospholipid Complexes
 
The required amounts of oxymatrine and phospholipids were placed in a 100 ml round-bottom flask and dissolved in tetrahydrofuran. After tetrahydrofuran was evaporated off under vacuum at 40°C, the dried residues were gathered and placed in desiccators overnight, then crushed in the mortar and sieved with a 100 mesh. The resultant oxymatrine–phospholipid complex was transferred into a glass bottle, flushed with nitrogen and stored in the room temperature.
 
Determination of the Content of Oxymatrine in Phospholipids Complex
 
The content of oxymatrine in phospholipids complex was determined as follows. Approximately 5mg of phospholipids complex were dissolved in 50 ml of solvent A (acetonitrile: dehydrated alcohol = 80:20, v/v), and a 20 μl aliquot of the resulting solution was injected into a HPLC system. The stationary phase, NH2 column (150mm×4.6 mm, 5μm), was kept at 25°C. The mobile phase was a mixture of acetonitrile : dehydrated alcohol: 3%H3PO4 (80:10:10, v/v). The flow rate was 1.0 ml/min. Effluent was monitored at 220 nm.
 
Differential Scanning Calorimetry (DSC)
 
The samples sealed in the aluminum crimp cell were heated at the speed of 5 μ·ml-1 from 0 to 300ml in the atmosphere of nitrogen (Dupont 1090B, Dupont, USA). Peak transition onset temperature was determined by means of an analyzer. The peak transition onset temperatures of phospholipids, pure oxymatrine, the mixture of phospholipids and oxymatrine and the oxymatrine-phospholipids complex were compared.
 
X-ray Diffractometry (XRD)
 
The X-ray diffractogram (D/max-r A, Rigaku Denki, Japan) was scanned with the diffraction angle increasing from 5° to 50°, 2θ angle, with a step angle of 0.04° and a count time of 1s.
 
N-octanol/water Partition Coefficient(P) of OMT-PLC
 
P of OMT determination of OMT material, phospholipids complex or the physical mixture was carried out by adding 0.2g of OMT material, phospholipids complex or physical mixture to a series of 10 ml water solutions(pH 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 7.5) in sealed glass containers at 25°C, respectively. Each experiment was performed in triplicate. All the sixty-three liquids were agitated for 24 h and centrifuged to remove excessive residues (15 min, 4000 rpm), respectively. Each liquid was added 10 ml n-octanol and agitated for 24 h. Then they were centrifuged at 4000 rpm for 15 min, respectively. The water phase and n-octanol phase were separated. The water phase and noctanol phase were filtrated through a 0.45μm membrane, respectively. The 1ml filtrate was mixed with 9ml of methanol and a 20μl aliquot of the resulting solution was injected into a HPLC and detected as the previous description, the concentrations of OMT were measured, respectively.
 
P of OMT of OMT material, physical mixture and phospholipids complex were calculated as follows:
 
P=CO/CW
 
where Co was the concentration of OMT material, OMT-PLC or the physical mixture in n-octanol; Cw was the concentration of OMT material, OMT-PLC or its physical mixture in water.
 
Rat Bioavailability Experiments
 
Capillary Electrophoresis
 
Capillary electrophoresis was performed on a HPCE instrument (Trisep-2010) equipped with a UV detector set at 205 nm (Luo et al., 1999). Separation and analysis were carried out on an uncoated fused-silica capillary tube (50μm I.D., 56 cm total length and 36 cm from the injection point to the detector) at 25°C. Before each run, the capillary tube was washed with 0.1 M NaOH for 5 min, bidistilled water for 5 min, and then with the operating buffer tris hydroxymethyl aminomethane (Tris,40mM)-sodium dihydrogen phosphate (10 mM)-4% avantin buffered at pH 7.6 for 5 min. The operating buffer used was degassed by vacuum filtration through a 0.2 μm membrane filter, followed by agitation in an ultrasonic bath. The samples to be analyzed were injected automatically, using the pressure injection mode, in which the sample is pressurized for 3 s. The electrophoresis was performed at 20 kV (about 50 mA) using normal polarity.
 
Plasma Sample Preparation and Validity
 
The rats were anaesthetized with aether, and 500μl blood was taken from the eyeground veins. The plasma was obtained after centrifugation (15 min, 4000 rpm) was stored at -20°C until analyzed. When the plasma sample was thawed, 50μl of cimetidine solution (CMD, 1.4 mg· ml-1, internal standard), 100μl of 1M Na2CO3 solution and 500μl of borate buffer saline (pH 8.0) were added, and agitated for 30 s. After 4ml aether was added to the solution above, this mixture was shaken for 3 min and then centrifuged (15 min, 4000 rpm). The organic phase was quantitatively decanted into a clear tapered centrifuging tube and the eluate was evaporated under nitrogen at 37°C. The residues were resuspended in 100μl of mobile phase and centrifuged (15 min, 4000 rpm). Aliquots (20μl) of the supernatant were injected for HPCE analysis.
 
Pharmacokinetic Studies of Oxymatrine–phospholipids Complex and Oxymatrine in Rats
 
Eighteen male rats (body weight 180~220g) divided randomly into three groups were fasted for 12 h, but allowed to take water freely. A sample equivalent to 100mg/kg of oxymatrine phospholipids complex suspended in 2ml of water was orally administered to one group of rats. The solutions of oxymatrine and physical mixture equivalent to100mg/kg of oxymatrine were orally administered to the other group of rats,repectively. Peak concentrations (Cmax) and peak times (Tmax) were derived directly from the experimental points. The other pharmacokinetical parameters were computed by software program 3p87.
 
Results and Discussion
 
Preparation of Oxymatrine –phospholipid Complex
 
We prepared oxymatrine –phospholipid complex according to different quantity ratio of phospholipids and drugs, such as 1, 2, 3 and 4. The results showed that when the ratio was more than 3, the appearance of resultant materials appeared viscous and it was not easy that resultant materials were prepared to other preparations, but when the ratio was lower than 3, the stability of phospholipid complexes was worse and the complex ratio was poor. For the purpose to get the best quality and use the fewest quantity ratio of phospholipids, at last we prepared oxymatrine–phospholipid complex in term of the quantity ratio 3. The content of oxymatrine in the phospholipids complex was 24.86% (w/w).
 
Differential Scanning Calorimetry
 
Figure 1 showed (included as a supplementary information) the DSC curves of phospholipids, oxymatrine physical mixture and phospholipids complex. DSC of phospholipids complex showed the endothermal peaks of oxymatrine and phospholipid are disappeared and the phase transition temperature is lower than the phase transition temperature of phospholipids, it was considered that oxymatrine and phospholipids should have some interaction, such as the combination of hydrogen bonds or van der Waals force (Venema et al., 1988; Lasonder et al., 1990). After the combination of oxymatrine and the phospholipids molecule polarity parts, the carbon–hydrogen chain in phospholipids could turn freely and enwrap the phospholipids molecule polarity parts, which made the sequence decrease between phospholipids aliphatic hydrocarbon chains, made the second endothermal peak of phospholipids disappear and depressed the phase transition temperature.
 
X-ray Diffractometry
 
Figure 2 shows (included as a supplementary information) the powder X-ray diffraction patterns of oxymatrine, phospholipids, their physical mixture and the complex. The oxymatrine powder diffraction pattern shown in Figure 2(c) displayed partial sharp crystalline peaks, which is the characteristic of a molecule with some crystallinity. In contrast, phospholipids shown in Figure2(b) were amorphous lacking crystalline peaks. Compared with that of the physical mixture, the crystalline peaks had disappeared in the complex shown in Figure 2(a). This suggested that oxymatrine in the phospholipids lipid matrix was either molecularly dispersed or amorphous form. However, as seen in Figure 2(d), some crystalline drug signal was still detectable in the physical mixtures of oxymatrine and phospholipids.
 
N-octanol/water Partition Coefficient(P) of OMT-PLC
 
Table 1 showed the n-octanol/water partition coefficient (P) of OMT, the physical mixture and OMT-PLC at different pH. The data showed that OMT-PLC markedly increased the lipophilicify of OMT, and P of OMT-PLC in n-octanol and water was about 10 multiples more than that of OMT material, these were due to the strong dispersibility or/and amorphous form of the phospholipids complexes and polar group of OMT were masked by phospholipids. However, P of OMT in physical mixture was about 4 multiples more than that of OMT material, because the phospholipids slightly improved the hydrophilicity and lipophilicify of OMT in physical mixture by means of its solubilization.
 
Table 1: N-octanol/water parti tion coefficient (P) of oxymatrine, physical mixture and OMT-PLC at different pH. Values are mean±S.D. (n=3).
 
Rats Bioavailability
 
Oxymatrine in plasma was completely separated under analytical conditions (Figure 3) (included as a supplementary information). The calibration curve was found to be linear 13.501- 0.046 (r=0.9992, where x is the concentration ratio of OTM to CA and y is the corresponding peak-area ratio UDCA/CA) in the 0.0179 to 0.1790 mg·ml-1 range.The results attained from the method recoveries of high, middle and low concentrations were 85.15, 87.11 and 88.37%, respectively. The R.S.D. in days were 3.18, 3.52 and 3.29%, respectively, the R.S.D. intra-days were 3.41, 3.74 and 3.45%, respectively, which showed recoveries and RSD in days or intra-days were satisfying, and the lowest detection limit was 35 ng·ml-1.
 
Figure 4 showed the sample equivalent to 100 mg/kg of oxymatrine of phospholipids complex and oxymatrine was respectively orally administered to rats (n = 6). From the above profile and Table 2, it was known that the average value of Cmax is 0.437 μg·ml-1 after oral administration of phospholipids complex with a Tmax of about 2.17 h. However, the average value of Cmax was 0.164 μg·ml-1 after oral administration of oxymatrine solution with a Tmax of about 1.71 h, the average value of Cmax was 0.247 μg·ml-1 after oral administration of oxymatrine solution with a Tmax of about 1.91 h. The average value of AUC0–∞ of oxymatrine ,the phtsical mixture and the complex in rats were 2.87, 3.23 and 9.43μg·h·ml-1, respectively. And the bioavailability of oxymatrine was 3.29 multiples than oxymatrine. The pharmacokinetical data were simulated by non-linear least squares. The results showed that open two-compartment model and 1st-order absorption were fitted to both phospholipids complex and oxymatrine plasma concentration–time course in vivo of rats.
 

Figure4: Mean BIA 2-005 plasma concentration-time profiles following oral administration of a single-dose of ESL 400 mg (n=20), 600 mg (n=19) and 800 mg (n=20), final formulation (Test) and research formulation (Reference). (a) Linear scale; (b) semilog scale.

 

Table 2: The main pharmacokinetic parameters of phospholipids complex ,physical mixture and oxymatrine in rats (n=6). *P<0.05 are statistical significances with the OMT-PLC versus OMT or physical mixture.

 
Conclusion
 
In this study, OMT-PLC was successfully prepared by a simple method. DSC and XRD curves of phospholipids complex showed that OMT and phospholipids combined and formed some kind bond, such as hydrogen bonds or van der Waals force. The N-octanol/water partition coefficient(P) of OMT-PLC studies showed OMT-PLC surprisingly increased the hydrophilicity and lipophilicify of OMT, and P of OMT-PLC in n-octanol and water was about 10 multiples more than that of UCDA material. The blood concentration of OMT was precisely assayed by HPCE Compared with OMT material and the physical mixture, the phosphol ipid complex can markedly improve the bioavailability of OMT in vivo of rats. It would be further studied about the absorbed mechanism of OMT-PLC through small intestine and therapeutic evaluation in vivo. The OMT-PLC
would be more prospective preparation in future.
 
Acknowledgements
 
The authors wish to thank the Chinese Medicine Modernization Foundation of Shanghai City for financial support (No. 05DZ19711).
 
References
 
  1. Chen Y, Li J, Zeng M, Lu L, Qu D, et al. (2001) The inhibitory effect of oxymatrine on hepatitis C virus in vitro. Zhonghua Ganzangbing Zazhi 9: 12-14.  »  PubMed  »  Google Scholar

  2. Chen XS, Wang GJ, Cai X, Yu HY, Hu YP (2001) Inhibition of hepati tis B virus by oxymatr ine in vivo. Wor ld J Gastroenterol 7: 49-52. »  CrossRef  »  PubMed  »  Google Scholar

  3. Chen YX, Mao BY, Jiang JH (2002) Relationship between serum load of HBV-DNA and therapeutic effect of oxymatrine in patients with chronic hepatitis B. Zhongguo Zhongxiyi Jiehe Zazhi 22: 335-336. »  PubMed  »  Google Scholar

  4. Dong Y, Xi H, Yu Y, Wang Q, Jiang K, et al. (2002) Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine. J Gastroenterol Hepatol 17: 1299-1306. »  CrossRef  »  PubMed  »  Google Scholar

  5. Lai JP, He XW, Jiang Y, Chen F (2003) Preparative separation and determination of matrine from the Chinese medicinal plant Sophora flavescens Ait by molecularly imprinted solid-phase extraction. Anal Bioanal Chem 375: 264- 269. »  CrossRef  »  PubMed  »  Google Scholar

  6. Lasonder E, Weringa WD (1990) An NMR and DSC study of the interaction of phospholipids vesicles with some antiinflammatory agents. J Colloid Interface Sci 139: 469-478. »  CrossRef »  Google Scholar

  7. Li J, Li C, Zeng M (1998) Preliminary study on therapeutic effect of oxymatrine in treating patients with chronic hepatitis C. Zhongguo Zhongxiyi Jiehe Zazhi 18: 227-229. »  PubMed  »  Google Scholar

  8. Liu J, Manheimer E, Tsutani K, Gluud C (2003) Medicinal herbs for hepatit is C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am J Gastroenterol 98: 538-544. »  CrossRef  »  PubMed  »  Google Scholar

  9. Luo M, He P, Wu M (1999) Determination of Matrine and Oxymatrine by HPCE. J Chinese Traditional and Herbal Drugs 30: 261-263.

  10. Venema FR, Weringa WD (1988) The interactions of phospholipid vesicles with some anti-inflammatory agents. J Colloid Interface Sci 125: 484-500. »  CrossRef  »  Google Scholar

  11. Wang BE (2000) Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol 15: E67-70. »  CrossRef  »  PubMed  »  Google Scholar

  12. Xiang X, Wang G, Cai X, Li Y (2002) Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis. Chin Med J 115: 593-596. »  CrossRef  »  PubMed  »  Google Scholar

  13. Yang W, Zeng M, Fan Z, Mao Y, Song Y, et al. (2002) Prophylactic and therapeutic effect of oxymatrine on D-galactosamine- induced rat liver fibrosis. Zhonghua Ganzangbing Zazhi 10: 193-196. »  PubMed  »  Google Scholar

  14. Yu YY, Wang QH, Zhu LM, Zhang QB, Xu DZ, et al. (2002) A clinical research on oxymatrine for the treatment of chronic hepatitis B. Zhonghua Ganzangbing Zazhi 10: 280-281.  »  PubMed  »  Google Scholar

 
 
 
This Article
DOWNLOAD
» XML (50 kB)
» PDF (206 kB)
» Citation
   
CONTRIBUTE
» Write a Response
» Read other Responses
» Publishing with OPG
   
SHARE
» E-mail This Article
» Print This Article
» Rights and Permissions
   
Share
EXPLORE
Related Article at
» Pubmed
» DOAJ
» Scholar Google
 
 
 
 
Untitled Document
| More
OMICS Publishing Group: An Open Access Publisher
OMICS Publishing Group is the member of/publishing partner of/source content provider to
All Published content, except where otherwise noted, is licensed under a Creative Commons Attribution License.